Optimal environmental conditions in life science facilities. Rudi Heymans

Size: px
Start display at page:

Download "Optimal environmental conditions in life science facilities. Rudi Heymans"

Transcription

1 Optimal environmental conditions in life science facilities Rudi Heymans

2 Seite 2 June 2009 Siemens NV/SA 2009

3 What are the reasons to think and talk about the environmental impact of the Life Science Industry? Global warming? Public image? Share Value? Company development? Optimize Operational Costs and Improve Competitiveness? It s about all of these topics! Seite 3 June 2009 Siemens NV/SA 2009

4 What are the reasons to think and talk about the environmental impact of the Life Science Industry? Global warming? Public image? Share Value? Company development? Optimize Operational Costs and Improve Competitiveness? It s about all of these topics! Seite 4 June 2009 Siemens NV/SA 2009

5 Distribution of Energy use in the Life Sciences energy consumption 25% Plug Other loads and processes Lighting 65% 10% HVAC Source: Energy Efficiency Improvement and Cost Saving Opportunities for Pharmaceutical Industry. Ernest Orlando Lawrence Berlely National Laboratory, Sept 2005 Seite 5 June 2009 Siemens NV/SA 2009

6 Distribution of Energy use in the Pharmacuetical Industry building types 15% 5% 5% 30% R&D Offices Bulk Manufacturing Formulation, Packaging & Filling Warehouses 10% Miscellaneous 35% Source: Energy Efficiency Improvement and Cost Saving Opportunities for Pharmaceutical Industry. Ernest Orlando Lawrence Berlely National Laboratory, Sept 2005 Seite 6 June 2009 Siemens NV/SA 2009

7 What are the reasons to think and talk about the environmental impact of the Life Science Industry? Global warming? Public image? Share Value? Company development? Optimize Operational Costs and Improve Competitiveness? It s about all of these topics! Seite 7 June 2009 Siemens NV/SA 2009

8 Pharmaceutical Companies Image In the US Pharmaceutical companies receive little recognition from the public for their social contributions and investments 60% of the interviewed individuals are the opinion that Pharma companies do not pay enough attention to their social an environmental responsibilities [source: Annabel Evans, Ipsos, April 11, 2007 ] Seite 8 June 2009 Siemens NV/SA 2009

9 What are the reasons to think and talk about the environmental impact of the Life Science Industry? Global warming? Public image? Share Value? Company development? Optimize Operational Costs and Improve Competitiveness? It s about all of these topics! Seite 9 June 2009 Siemens NV/SA 2009

10 DJSI Application for Pharma companies ECONOMIC DIMENSION (37%) Brand Management Customer Relationship Management Marketing Practices Research and Development SOCIAL DIMENSION (45%) Animal Testing Bioethics Occupational Health&Safety Stakeholder Engagement Standards for Suppliers Strategy to Improve Access to Drugs ENVIRONMENTAL DIMENSION (18%) Advanced Environmental Performance Climate Strategy Environmental Policy/ Management System Seite 10 June 2009 Siemens NV/SA 2009

11 What are the reasons to think and talk about the environmental impact of the Life Science Industry? Global warming? Public image? Share Value? Company development? Optimize Operational Costs and Improve Competitiveness? It s about all of these topics! Seite 11 June 2009 Siemens NV/SA 2009

12 Systems to provide energy reducing solutions & compliant environment conditions Calibrated/certified Field Devices Laboratory Solution GAMP compliant HVAC automation Compact Monitoring Technology CMT Validated Access Control + Compliant Total Building Solutions Operation and Supervision Seite 12 June 2009 Archiving and Reporting Electronic Validation Tool Vendor Audit Reports Siemens NV/SA 2009

13 Siemens Laboratory Solution Flexible and fully integrated solution to control complex air flow and optimize your energy consumption Dedicated energy consumption report per user An overview of your system functionality More Reliable All information available to improve your maintenance Seite 13 June 2009 Siemens NV/SA 2009

14 All you need for validation We follow the recommendation of the GAMP 5 s V-Model Risk based approach Pre tested, pre configured Traceability Documentation management URS FS SDS Verification checklist Time to Market risk minimizing Cost reducing CMP FATS SAT Traditional IQ/OQ SATS Design Review FAT Seite 14 June 2009 Siemens NV/SA 2009

15 What are the reasons to think and talk about the environmental impact of the Life Science Industry? Global warming? Public image? Share Value? Company Development? development? Optimize operational Operational cost Costs and and Improve competitiveness? Competitiveness? It s about all of these topics! Seite 15 June 2009 Siemens NV/SA 2009

16 Thank you for your attention Rudi Heymans